Robert Ross Carter - 21 May 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Financial Officer
Signature
/s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter
Issuer symbol
TOI
Transactions as of
21 May 2025
Net transactions value
-$4,283
Form type
4
Filing time
22 May 2025, 14:12:47 UTC
Previous filing
02 Apr 2025
Next filing
19 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carter Robert Ross Chief Financial Officer C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER RD #800, CERRITOS /s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter 22 May 2025 0002039341

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Class A Common Stock Disposed to Issuer $4,283 -1,601 -0.68% $2.68 235,174 21 May 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.